Participants in the Active RA group had markedly elevated CRP levels (12.8 mg/dL ± 14) compared to the Control group (3.22 mg/dL ± 1.92) and the Remission group (3.11 mg/dL ± 1) (p < 0.001 for both comparisons). This evidence concerns the gene CRP and rheumatoid arthritis.